Yuan Shuo-Fu, Brooks Sierra M, Nguyen Annalee W, Lin Wen-Ling, Johnston Trevor G, Maynard Jennifer A, Nelson Alshakim, Alper Hal S
Institute for Cellular and Molecular Biology, The University of Texas at Austin, Austin, TX, USA.
McKetta Department of Chemical Engineering, The University of Texas at Austin, Austin, TX, USA.
Bioact Mater. 2021 Jan 27;6(8):2390-2399. doi: 10.1016/j.bioactmat.2021.01.019. eCollection 2021 Aug.
Traditional production of industrial and therapeutic proteins by eukaryotic cells typically requires large-scale fermentation capacity. As a result, these systems are not easily portable or reusable for on-demand protein production applications. In this study, we employ Bioproduced Proteins On Demand (Bio-POD), a F127-bisurethane methacrylate hydrogel-based technique that immobilizes engineered for preservable, on-demand production and secretion of medium- and high-molecular weight proteins (in this case, SEAP, α-amylase, and anti-HER2). The gel samples containing encapsulated-yeast demonstrated sustained protein production and exhibited productivity immediately after lyophilization and rehydration. The hydrogel platform described here is the first hydrogel immobilization using a system to produce recombinant proteins of this breadth. These results highlight the potential of this formulation to establish a cost-effective bioprocessing strategy for on-demand protein production.
真核细胞传统生产工业和治疗性蛋白质通常需要大规模发酵能力。因此,这些系统不易于移植或重复用于按需蛋白质生产应用。在本研究中,我们采用了按需生物生产蛋白质(Bio-POD)技术,这是一种基于F127-双异氰酸酯甲基丙烯酸酯水凝胶的技术,该技术固定工程化酵母用于中、高分子量蛋白质(在本案例中为SEAP、α-淀粉酶和抗HER2)的可保存、按需生产和分泌。含有包囊酵母的凝胶样品显示出持续的蛋白质生产,并在冻干和复水后立即展现出生产力。此处描述的水凝胶平台是首个使用酵母系统固定化来生产如此多种重组蛋白的水凝胶。这些结果突出了该制剂建立一种用于按需蛋白质生产的经济高效生物加工策略的潜力。